Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oyster Point Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oyster Point Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lainovic Sacha | Director, 10% Owner | 0Indirect | Jan 5, 2023 | 0 |
| InvOpps IV US, L.P. | Director, 10% Owner | 0Indirect | Jan 5, 2023 | 0 |
| InvOpps GP IV, L.L.C. | Director, 10% Owner | 0Indirect | Jan 5, 2023 | 0 |
| InvOpps IV, L.P. | Director, 10% Owner | 0Indirect | Jan 5, 2023 | 0 |
| Versant Ventures IV, LLC | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Venture Capital IV, L.P. | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Side Fund IV, L.P. | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Venture Capital VI, L.P. | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Vantage I, L.P. | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Vantage I GP, L.P. | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Ventures VI GP-GP, LLC | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Vantage I GP-GP, LLC | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Versant Ventures VI GP, L.P. | 10% Owner | 0Indirect | Jan 4, 2023 | 0 |
| Kerins Patrick J | 10% Owner | 0 | Jan 4, 2023 | 0 |
| Sandell Scott D | 10% Owner | 0 | Jan 4, 2023 | 0 |
| Baskett Forest | 10% Owner | 0 | Jan 4, 2023 | 0 |
| New Enterprise Associates 14, L.P. | 10% Owner | 0 | Jan 4, 2023 | 0 |
| NEA Partners 14, L.P. | 10% Owner | 0 | Jan 4, 2023 | 0 |
| Nea 14 GP, Ltd | 10% Owner | 0 | Jan 4, 2023 | 0 |
| Sonsini Peter W. | 10% Owner | 0 | Jan 4, 2023 | 0 |
| Atieh Michael G | Director | 0 | Jan 4, 2023 | 0 |
| Weisner Aimee S | Director | 0 | Jan 4, 2023 | 0 |
| Santel Donald J | Director | 0 | Jan 4, 2023 | 0 |
| Behbahani Ali | Director | 0 | Jan 4, 2023 | 0 |
| Ozawa Clare | Director | 0Indirect | Jan 4, 2023 | 0 |
| Nau Jeffrey | President and CEO | 0Indirect | Jan 4, 2023 | 0 |
| Lochner Daniel | Chief Financial Officer | 0 | Jan 4, 2023 | 0 |
| Tsai Benjamin | Director | 0 | Jan 4, 2023 | 0 |
| Murray Mark Anthony | Director | 0 | Jan 4, 2023 | 0 |
| Eliades George Christopher | Director | 0 | Jan 4, 2023 | 0 |
| Snisarenko John | Chief Commercial Officer | 30,322 | Jan 11, 2022 | 0 |
| Link William J PhD | Director | 2,074Indirect | Jan 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 (view filing)4:38 PM ET | Oct 18 | 2 days | Versant Ventures IV, LLC and 8 others10% Owner | SSale | −550.0K | $14.84 | −$8.16M | −99.1%4.99K after | 4 lots |
| Oct 20, 2021 (view filing) | Oct 18 | 2 days | Link William J PhDDirector | SSale | −550.0K | $14.83 | −$8.16M | −99.1%4.99K after | 4 lotsDuplicate filing |
| Oct 20, 2021 (view filing) | Oct 18 | 2 days | Ozawa ClareDirector, 10% Owner | SSale | −550.0K | $14.83 | −$8.16M | −99.1%4.99K after | 4 lots |